BMC Health Serv Res June 2023 PMID 37309002

Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees.

Elkanah Linder, Björn Wettermark, Marie-Louise Ovesjö, Sofia Kälvemark Sporrong, Helena Ramström

Mentions

2
Peak: 1 in Jun 2023
across 2 sources since Jun 2023

Extended reach

43
potential audience

Total likes

0

Video views

14

Mentions per month

Jun 2023 – Sep 2023

Where it's discussed

  • X / Twitter1 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions highlight the significance of the publication by emphasizing the necessity for improved data transparency and the role of environmental information in decision-making, with phrases like 'crucial for future policies' and 'must address data gaps' indicating high engagement and concern for impactful change.

AgreementModerate agreement

Most discussions acknowledge the value and importance of the study, with some emphasizing the need for better data and transparency, reflecting general agreement on its conclusions.

InterestHigh interest

Participants show strong interest, with many referencing the practical implications for healthcare decision-making and environmental policies.

EngagementHigh engagement

The discussions are detailed, with users analyzing specific issues like data gaps, industry transparency, and legislation, indicating deep engagement.

ImpactModerate impact

While some recognize the study's influence on policy and practice, others suggest ongoing challenges, so the perceived impact is moderate but meaningful.

Abstract in brief

  • The study examined how Swedish Drug and Therapeutics Committees (DTCs) use environmental information on pharmaceuticals from two publicly available systems, Janusinfo and Fass, highlighting that DTCs rely on these tools for decision-making and education but face challenges such as data gaps and industry transparency issues.
  • Survey results showed that DTCs are more familiar with Janusinfo and value its concrete proposals, though they wish all medications had environmental info on Fass and want better data, clearer messages, and supportive legislation to help address pharmaceuticals' environmental impacts.
  • Overall, the research indicates that environmental knowledge supports DTCs’ efforts but also reveals significant hurdles they need to overcome, like data transparency and industry cooperation, to better incorporate environmental considerations into healthcare practices.

Top posts

Most liked on X and Bluesky
BioSoftwarePapers
@biosoft_paper · X

Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees https://t.co/d3abOLY3pq

Jun 13, 2023 · 30 followers View post →

All mentions

BioSoftwarePapers
@biosoft_paper · X

Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees https://t.co/d3abOLY3pq

Jun 13, 2023 · 30 followers View post →